Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

NVE (NASDAQ:NVEC)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more NVE Charts.

NVE (NASDAQ:NVEC)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more NVE Charts.

NVE Corporation News

Form 8-K/A - Current report: [Amend]
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend
Wednesday 22 January 2025 (1 month ago) • Business Wire

NVE Schedules Conference Call on Third-Quarter Results
Thursday 16 January 2025 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 5 December 2024 (3 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 3 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 23 October 2024 (4 months ago) • Edgar (US Regulatory)

More NVE Corporation News Articles

Valiant Eagle (PK)

Anavex Life Sciences

Rennova Health (CE)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Global Developments (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions